These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21048668)

  • 21. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of loureirin A against Candida albicans biofilms.
    Lin MY; Yuan ZL; Hu DD; Hu GH; Zhang RL; Zhong H; Yan L; Jiang YY; Su J; Wang Y
    Chin J Nat Med; 2019 Aug; 17(8):616-623. PubMed ID: 31472899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms].
    Valentín A; Cantón E; Pemán J; Quindós G
    Rev Iberoam Micol; 2007 Dec; 24(4):272-7. PubMed ID: 18095759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal activity of a β-peptide in synthetic urine media: Toward materials-based approaches to reducing catheter-associated urinary tract fungal infections.
    Raman N; Lee MR; Rodríguez López AL; Palecek SP; Lynn DM
    Acta Biomater; 2016 Oct; 43():240-250. PubMed ID: 27422198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms.
    Luiz RL; Vila TV; de Mello JC; Nakamura CV; Rozental S; Ishida K
    BMC Complement Altern Med; 2015 Mar; 15():68. PubMed ID: 25886244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay.
    Nett JE; Cain MT; Crawford K; Andes DR
    J Clin Microbiol; 2011 Apr; 49(4):1426-33. PubMed ID: 21227984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
    J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
    Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
    Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
    Jia W; Zhang H; Li C; Li G; Liu X; Wei J
    BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation.
    Pierce CG; Saville SP; Lopez-Ribot JL
    Pathog Dis; 2014 Apr; 70(3):423-31. PubMed ID: 24623598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role for cell density in antifungal drug resistance in Candida albicans biofilms.
    Perumal P; Mekala S; Chaffin WL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2454-63. PubMed ID: 17502416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro analysis of flufenamic acid activity against Candida albicans biofilms.
    Chavez-Dozal AA; Jahng M; Rane HS; Asare K; Kulkarny VV; Bernardo SM; Lee SA
    Int J Antimicrob Agents; 2014 Jan; 43(1):86-91. PubMed ID: 24156913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
    Singh R; Kumari A; Kaur K; Sethi P; Chakrabarti A
    J Med Microbiol; 2018 Jul; 67(7):922-926. PubMed ID: 29767615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
    Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
    Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical composition and antifungal activity of Satureja hortensis L. essentiall oil against planktonic and biofilm growth of Candida albicans isolates from buccal lesions of HIV(+) individuals.
    Sharifzadeh A; Khosravi AR; Ahmadian S
    Microb Pathog; 2016 Jul; 96():1-9. PubMed ID: 27126187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of eugenol against Candida albicans biofilms.
    He M; Du M; Fan M; Bian Z
    Mycopathologia; 2007 Mar; 163(3):137-43. PubMed ID: 17356790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
    Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H
    J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces.
    Kuhn DM; Chandra J; Mukherjee PK; Ghannoum MA
    Infect Immun; 2002 Feb; 70(2):878-88. PubMed ID: 11796623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A quantitative real-time RT-PCR assay for mature C. albicans biofilms.
    Xie Z; Thompson A; Kashleva H; Dongari-Bagtzoglou A
    BMC Microbiol; 2011 May; 11():93. PubMed ID: 21548962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent insights into Candida albicans biofilm resistance mechanisms.
    Mathé L; Van Dijck P
    Curr Genet; 2013 Nov; 59(4):251-64. PubMed ID: 23974350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.